|
1
|
Michalski MN and McCauley LK: Macrophages
and skeletal health. Pharmacol Ther. 174:43–54. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holliday LS, McHugh KP, Zuo J, Aguirre JI,
Neubert JK and Rody WJ Jr.: Exosomes: Novel regulators of bone
remodelling and potential therapeutic agents for orthodontics.
Orthod Craniofac Res. 20 Suppl 1:S95–S99. 2017. View Article : Google Scholar
|
|
3
|
Iqbal J, Yuen T, Kim SM and Zaidi M:
Opening windows for bone remodeling through a SLIT. J Clin Invest.
128:1255–1257. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boucher E, Marin M, Holani R, Young-Speirs
M, Moore DM and Cobo ER: Characteristic pro-inflammatory cytokines
and host defence cathelicidin peptide produced by human
monocyte-derived macrophages infected with Neospora caninum.
Parasitology. 1–14. 2017.
|
|
5
|
Mishra N, Mohata M, Aggarwal H, Chaudhary
O, Das BK, Sinha S, Hazarika A and Luthra K: Expression of
complement receptor 3 (CR3) and regulatory protein CD46 on
dendritic cells of antiretroviral naive and treated HIV-1 infected
individuals: Correlation with immune activation status. Mol
Immunol. 96:83–87. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sheikh V, Kasapoglu P, Zamani A, Basiri Z,
Tahamoli-Roudsari A and Alahgholi-Hajibehzad M: Vitamin D3 inhibits
the proliferation of T helper cells, downregulate CD4+ T
cell cytokines and upregulate inhibitory markers. Hum Immunol.
79:439–445. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yano S, Mentaverri R, Kanuparthi D,
Bandyopadhyay S, Rivera A, Brown EM and Chattopadhyay N: Functional
expression of beta-chemokine receptors in osteoblasts: role of
regulated upon activation, normal T cell expressed and secreted
(RANTES) in osteoblasts and regulation of its secretion by
osteoblasts and osteoclasts. Endocrinology. 146:2324–2335. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fuller K, Owens JM and Chambers TJ:
Macrophage inflammatory protein-1 alpha and IL-8 stimulate the
motility but suppress the resorption of isolated rat osteoclasts. J
Immunol. 154:6065–6072. 1995.PubMed/NCBI
|
|
9
|
Moreaux J, Hose D, Kassambara A, Reme T,
Moine P, Requirand G, Goldschmidt H and Klein B: Osteoclast-gene
expression profiling reveals osteoclast-derived CCR2 chemokines
promoting myeloma cell migration. Blood. 117:1280–1290. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Palmqvist P, Persson E, Conaway HH and
Lerner UH: IL-6, leukemia inhibitory factor and oncostatin M
stimulate bone resorption and regulate the expression of receptor
activator of NF-kappa B ligand, osteoprotegerin and receptor
activator of NF-kappa B in mouse calvariae. J Immunol.
169:3353–3362. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang WH, Tsai CH, Fong YC, Huang YL, Wang
SJ, Chang YS and Tang CH: Leptin induces oncostatin M production in
osteoblasts by downregulating miR-93 through the Akt signaling
pathway. Int J Mol Sci. 15:15778–15790. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Richards CD, Langdon C, Deschamps P,
Pennica D and Shaughnessy SG: Stimulation of osteoclast
differentiation in vitro by mouse oncostatin M, leukaemia
inhibitory factor, cardiotrophin-1 and interleukin 6: Synergy with
dexamethasone. Cytokine. 12:613–621. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Walker EC, McGregor NE, Poulton IJ, Solano
M, Pompolo S, Fernandes TJ, Constable MJ, Nicholson GC, Zhang JG,
Nicola NA, et al: Oncostatin M promotes bone formation
independently of resorption when signaling through leukemia
inhibitory factor receptor in mice. J Clin Invest. 120:582–592.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kakutani Y, Shioi A, Shoji T, Okazaki H,
Koyama H, Emoto M and Inaba M: Oncostatin M promotes osteoblastic
differentiation of human vascular smooth muscle cells through
JAK3-STAT3 pathway. J Cell Biochem. 116:1325–1333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen CY, Su CM, Huang YL, Tsai CH, Fuh LJ
and Tang CH: CCN1 induces oncostatin M production in osteoblasts
via integrin-dependent signal pathways. PLoS One. 9:e1066322014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sarkozi R, Corazza U, Osterkamp JP,
Pirklbauer M, Mayer G and Schramek H: Synergistic induction of
CCL2/MCP-1 expression driven by oncostatin M and IL-1β in human
proximal tubular cells depends on STAT3 and p65 NFκB/RelA. Physiol
Rep. 3:e122982015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schnittker D, Kwofie K, Ashkar A, Trigatti
B and Richards CD: Oncostatin M and TLR-4 ligand synergize to
induce MCP-1, IL-6 and VEGF in human aortic adventitial fibroblasts
and smooth muscle cells. Mediators Inflamm. 2013:3175032013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pasquier J, Gosset M, Geyl C,
Hoarau-Vechot J, Chevrot A, Pocard M, Mirshahi M, Lis R, Rafii A
and Touboul C: CCL2/CCL5 secreted by the stroma induce IL-6/PYK2
dependent chemoresistance in ovarian cancer. Mol Cancer. 17:472018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Polacchini A, Girardi D, Falco A, Zanotta
N, Comar M, De Carlo NA and Tongiorgi E: Distinct CCL2, CCL5,
CCL11, CCL27, IL-17, IL-6, BDNF serum profiles correlate to
different job-stress outcomes. Neurobiol Stress. 8:82–91. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Garcia-Velasco JA, Seli E and Arici A:
Regulation of monocyte chemotactic protein-1 expression in human
endometrial stromal cells by integrin-dependent cell adhesion. Biol
Reprod. 61:548–552. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lisignoli G, Piacentini A, Cristino S,
Grassi F, Cavallo C, Cattini L, Tonnarelli B, Manferdini C and
Facchini A: CCL20 chemokine induces both osteoblast proliferation
and osteoclast differentiation: Increased levels of CCL20 are
expressed in subchondral bone tissue of rheumatoid arthritis
patients. J Cell Physiol. 210:798–806. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bojic S, Kotur-Stevuljevic J, Aleksic A,
Gacic J, Memon L and Simic-Ogrizovic S: Matrix metalloproteinase-9
and tissue inhibitor of matrix metalloproteinase-1 in sepsis after
major abdominal surgery. Dis Markers. 2018:50646842018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gershtein ES, Mushtenko SV, Ermilova VD,
Levchenko NE and Kushlinskii NE: Matrix metalloproteinases and
their tissue inhibitors in blood serum of patients with endometrial
cancer: Clinical and morphological correlations. Bull Exp Biol Med.
165:75–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Paiva KBS and Granjeiro JM: Matrix
metalloproteinases in bone resorption, remodeling and repair. Prog
Mol Biol Transl Sci. 148:203–303. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Clark IM, Powell LK, Ramsey S, Hazleman BL
and Cawston TE: The measurement of collagenase, tissue inhibitor of
metalloproteinases (TIMP) and collagenase-TIMP complex in synovial
fluids from patients with osteoarthritis and rheumatoid arthritis.
Arthritis Rheum. 36:372–379. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Walakovits LA, Moore VL, Bhardwaj N,
Gallick GS and Lark MW: Detection of stromelysin and collagenase in
synovial fluid from patients with rheumatoid arthritis and
posttraumatic knee injury. Arthritis Rheum. 35:35–42. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jablonska-Trypuc A, Matejczyk M and
Rosochacki S: Matrix metalloproteinases (MMPs), the main
extracellular matrix (ECM) enzymes in collagen degradation, as a
target for anticancer drugs. J Enzyme Inhib Med Chem. 31 Sup
1:S177–S183. 2016. View Article : Google Scholar
|
|
28
|
Fan X, Hughes BG, Ali MA, Chan BY, Launier
K and Schulz R: Matrix metalloproteinase-2 in oncostatin M-induced
sarcomere degeneration in cardiomyocytes. Am J Physiol Heart Circ
Physiol. 311:H183–H189. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ko HS, Park BJ, Choi SK, Kang HK, Kim A,
Kim HS, Park IY and Shin JC: STAT3 and ERK signaling pathways are
implicated in the invasion activity by oncostatin M through
induction of matrix metalloproteinases 2 and 9. Yonsei Med J.
57:761–768. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Komar HM, Hart PA, Cruz-Monserrate Z,
Conwell DL and Lesinski GB: Local and systemic expression of
immunomodulatory factors in chronic pancreatitis. Pancreas.
46:986–993. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wehmeyer C, Pap T, Buckley CD and Naylor
AJ: The role of stromal cells in inflammatory bone loss. Clin Exp
Immunol. 189:1–11. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bozec A and Zaiss MM: T regulatory cells
in bone remodelling. Curr Osteoporos Rep. 15:121–125. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tian DS, Peng J, Murugan M, Feng LJ, Liu
JL, Eyo UB, Zhou LJ, Mogilevsky R, Wang W and Wu LJ: Chemokine
CCL2-CCR2 signaling induces neuronal cell death via STAT3
activation and IL-1β production after status epilepticus. J
Neurosci. 37:7878–7892. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bauer D, Redmon N, Mazzio E and Soliman
KF: Apigenin inhibits TNFα/IL-1α-induced CCL2 release through
IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells.
PloS One. 12:e01755582017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
de Jager SC, Bongaerts BW, Weber M,
Kraaijeveld AO, Rousch M, Dimmeler S, van Dieijen-Visser MP,
Cleutjens KB, Nelemans PJ, van Berkel TJ, et al: Chemokines
CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk
predictors of short-term mortality in patients with acute coronary
syndromes. PLoS One. 7:e458042012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Amarasekara DS, Yun H, Kim S, Lee N, Kim H
and Rho J: Regulation of osteoclast differentiation by cytokine
networks. Immune Netw. 18:e82018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kawamura N, Kugimiya F, Oshima Y, Ohba S,
Ikeda T, Saito T, Shinoda Y, Kawasaki Y, Ogata N, Hoshi K, et al:
Akt1 in osteoblasts and osteoclasts controls bone remodeling. PLoS
One. 2:e10582007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang G, Sun Q, Teng Y, Li F, Weng T and
Yang X: PTEN deficiency causes dyschondroplasia in mice by enhanced
hypoxia-inducible factor 1alpha signaling and endoplasmic reticulum
stress. Development. 135:3587–3597. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang Y, Li X, Du J, Yin Y and Li Y:
Involvement of microRNAs-MMPs-E-cadherin in the migration and
invasion of gastric cancer cells infected with Helicobacter pylori.
Exp Cell Res. 367:196–204. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Filanti C, Dickson GR, Di Martino D, Ulivi
V, Sanguineti C, Romano P, Palermo C and Manduca P: The expression
of metalloproteinase-2, −9 and −14 and of tissue inhibitors-1 and
−2 is developmentally modulated during osteogenesis in vitro, the
mature osteoblastic phenotype expressing metalloproteinase-14. J
Bone Min Res. 15:2154–2168. 2000. View Article : Google Scholar
|
|
42
|
Slompo C, Buzalaf CP, Damante CA, Martins
GM, Hannas AR, Buzalaf MA and Oliveira RC: Fluoride modulates
preosteoblasts viability and matrix metalloproteinases-2 and −9
activities. Braz Dent J. 23:629–634. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Leung K: 123I-c(RGDfK)-human
serum albumin-tissue inhibitor of matrix metalloproteinase 2 fusion
protein: Molecular Imaging and Contrast Agent Database
(MICAD)National Center for Biotechnology Information (US). Bethesda
(MD): 2004
|
|
44
|
Hanabayashi M, Takahashi N, Sobue Y,
Hirabara S, Ishiguro N and Kojima T: Hyaluronan oligosaccharides
induce MMP-1 and −3 via transcriptional activation of NF-κB and p38
MAPK in rheumatoid synovial fibroblasts. PLoS One. 11:e01618752016.
View Article : Google Scholar : PubMed/NCBI
|
